AU2005238281A1 - A protein involved in cancer - Google Patents

A protein involved in cancer Download PDF

Info

Publication number
AU2005238281A1
AU2005238281A1 AU2005238281A AU2005238281A AU2005238281A1 AU 2005238281 A1 AU2005238281 A1 AU 2005238281A1 AU 2005238281 A AU2005238281 A AU 2005238281A AU 2005238281 A AU2005238281 A AU 2005238281A AU 2005238281 A1 AU2005238281 A1 AU 2005238281A1
Authority
AU
Australia
Prior art keywords
polypeptide
flj20584
cancer
agent
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005238281A
Other languages
English (en)
Inventor
Lindsey Jane Hudson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of AU2005238281A1 publication Critical patent/AU2005238281A1/en
Assigned to UCB PHARMA S.A. reassignment UCB PHARMA S.A. Request for Assignment Assignors: CELLTECH R&D LIMITED
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU2005238281A 2004-05-05 2005-05-04 A protein involved in cancer Abandoned AU2005238281A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0410021.0 2004-05-05
GBGB0410021.0A GB0410021D0 (en) 2004-05-05 2004-05-05 A protein involved in cancer
PCT/GB2005/001669 WO2005105835A1 (en) 2004-05-05 2005-05-04 A protein involved in cancer

Publications (1)

Publication Number Publication Date
AU2005238281A1 true AU2005238281A1 (en) 2005-11-10

Family

ID=32482711

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005238281A Abandoned AU2005238281A1 (en) 2004-05-05 2005-05-04 A protein involved in cancer

Country Status (7)

Country Link
US (1) US20070269431A1 (https=)
EP (1) EP1747234A1 (https=)
JP (1) JP2008509082A (https=)
AU (1) AU2005238281A1 (https=)
CA (1) CA2562181A1 (https=)
GB (1) GB0410021D0 (https=)
WO (1) WO2005105835A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL300418B2 (en) * 2020-08-06 2024-11-01 Univ Tsinghua Chemical synthesis of large and mirror-image proteins and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020029A1 (en) * 1998-10-05 2000-04-13 Genzyme Corporation Genes differentially expressed in cancer cells to design cancer vaccines
US20070224201A1 (en) * 2002-10-02 2007-09-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2005037865A2 (en) * 2003-10-16 2005-04-28 Zymogenetics, Inc. Ztnfr14, A TUMOR NECROSIS FACTOR RECEPTOR

Also Published As

Publication number Publication date
JP2008509082A (ja) 2008-03-27
GB0410021D0 (en) 2004-06-09
CA2562181A1 (en) 2005-11-10
US20070269431A1 (en) 2007-11-22
WO2005105835A1 (en) 2005-11-10
EP1747234A1 (en) 2007-01-31

Similar Documents

Publication Publication Date Title
US9120860B2 (en) Protein involved in ovarian cancer
JP4446036B2 (ja) 上皮誘導性癌の治療のための薬剤組成物
AU2003249072B2 (en) PTK7 protein involvement in carcinoma
US20070142276A1 (en) Protein involved in carcinoma
JP2010101901A (ja) 癌に関与するタンパク質
US20070269431A1 (en) Protein Involved In Cancer
US20070141061A1 (en) Protein involved in carcinoma
US20090214540A1 (en) Protein involved in cancer
WO2005105143A2 (en) Vaccines and antibodies against ltk for therapy of cancers.
WO2006000753A2 (en) Use of flj40787, a protein involved in colon, colorectal, ovarian, lung and/or liver cancer
GB2455634A (en) Treatment of cancer
WO2006003427A1 (en) A protein involved in carcinoma
JP2010117358A (ja) 癌に関与するタンパク質
WO2005049066A2 (en) Use of dudulin2 for the treatment or prophylaxis of lung cancer
WO2005019257A1 (en) A protein involved in pancreatic cancer

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: UCB PHARMA S.A.

Free format text: FORMER APPLICANT(S): CELLTECH R&D LIMITED

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period